Puig-Tintoré LM - Search Results

1

Epidemiology and costs of screening and management of precancerous lesions of the cervix in Spain.

Castellsagué X, Rémy V, Puig-Tintoré LM, de la Cuesta RS, Gonzalez-Rojas N, Cohet C. Castellsagué X, et al. Among authors: puig tintore lm. J Low Genit Tract Dis. 2009 Jan;13(1):38-45. doi: 10.1097/LGT.0b013e318182cd89. J Low Genit Tract Dis. 2009. PMID: 19098605

2

Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain.

Puig-Tintoré LM, Castellsagué X, Torné A, de Sanjosé S, Cortés J, Roura E, Méndez C, Bosch FX. Puig-Tintoré LM, et al. J Low Genit Tract Dis. 2008 Apr;12(2):82-9. doi: 10.1097/LGT.0b013e3181599c16. J Low Genit Tract Dis. 2008. PMID: 18369300

3

Epidemiology and cost of treatment of genital warts in Spain.

Castellsagué X, Cohet C, Puig-Tintoré LM, Acebes LO, Salinas J, San Martin M, Breitscheidel L, Rémy V. Castellsagué X, et al. Among authors: puig tintore lm. Eur J Public Health. 2009 Jan;19(1):106-10. doi: 10.1093/eurpub/ckn127. Epub 2008 Dec 26. Eur J Public Health. 2009. PMID: 19112075

4

Current techniques in screening for cervical cancer in Spain: updated recommendations.

Puig-Tintoré LM, Torné A, Alonso I. Puig-Tintoré LM, et al. Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S8-S10. doi: 10.1016/j.ygyno.2008.05.013. Epub 2008 Jul 7. Gynecol Oncol. 2008. PMID: 18606440

5

High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.

Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Garcia S, Campo E, Pahisa J, Ordi J. Alonso I, et al. Among authors: puig tintore lm. Am J Obstet Gynecol. 2007 Oct;197(4):359.e1-6. doi: 10.1016/j.ajog.2007.01.023. Epub 2007 Aug 21. Am J Obstet Gynecol. 2007. PMID: 17714678

6

Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.

Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Campo E, Pahisa J, Ordi J. Alonso I, et al. Gynecol Oncol. 2006 Nov;103(2):631-6. doi: 10.1016/j.ygyno.2006.04.016. Epub 2006 Jun 14. Gynecol Oncol. 2006. PMID: 16780934

7

Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.

Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, Keller T, von Knebel Doeberitz M, Neumann HH, Puig-Tintore LM, Sideri M, Rehm S, Ridder R; PALMS Study Group. Ikenberg H, et al. Among authors: puig tintore lm. J Natl Cancer Inst. 2013 Oct 16;105(20):1550-7. doi: 10.1093/jnci/djt235. Epub 2013 Oct 4. J Natl Cancer Inst. 2013. PMID: 24096620 Free PMC article.

8

Clinical role of cervical cancer vaccination: when and whom to vaccinate?

Torné A, Alonso I, Puig-Tintoré LM, Pahisa J. Torné A, et al. Among authors: puig tintore lm. Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S15-6. doi: 10.1016/j.ygyno.2008.06.015. Epub 2008 Jul 17. Gynecol Oncol. 2008. PMID: 18635253

9

Human papillomavirus load in Hybrid Capture II assay: does increasing the cutoff improve the test?

Ordi J, Alonso I, Torné A, Esteve R, Sierra E, Campo E, Puig-Tintoré LM. Ordi J, et al. Gynecol Oncol. 2005 Nov;99(2):313-9. doi: 10.1016/j.ygyno.2005.07.011. Epub 2005 Aug 19. Gynecol Oncol. 2005. PMID: 16112180

10

The use of sentinel lymph nodes in gynaecological malignancies.

Torné A, Puig-Tintoré LM. Torné A, et al. Curr Opin Obstet Gynecol. 2004 Feb;16(1):57-64. doi: 10.1097/00001703-200402000-00011. Curr Opin Obstet Gynecol. 2004. PMID: 15128009 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page